Effects of Aggressive Statin Therapy on Patients With Coronary Saphenous Vein Bypass Grafts: A Systematic Review and Meta-Analysis of Randomized, Controlled Trials.
CONCLUSIONS: Compared with moderate statin therapy, long-term aggressive statin lowered the LDL-C level significantly, further decreased the atherosclerotic progression of SVG, reduced the risks of repeated myocardial infarction and coronary revascularization after CABG, and revealed similar patient compliance and statin-related adverse effects but slightly increased myopathy events and aminotransferase levels.
PMID: 23932462 [PubMed - as supplied by publisher]
Source: Clinical Therapeutics - Category: Drugs & Pharmacology Authors: Kang S, Liu Y, Liu XB Tags: Clin Ther Source Type: research
More News: Atorvastatin Calcium | Cholesterol | Coronary Artery Bypass Graft | Drugs & Pharmacology | Heart Attack | Lipitor | Pravastatin | Science | Simvastatin | Statin Therapy | Study | Zivast | Zocor